The global oral clinical nutrition market size was exhibited at USD 15.9 billion in 2022 and is projected to hit around USD 16.73 billion by 2032, growing at a CAGR of 5.2% during the forecast period 2023 to 2032.
Key Pointers:
Oral Clinical Nutrition Market Report Scope
Report Coverage |
Details |
Market Size in 2023 |
USD 16.73 Billion |
Market Size by 2032 |
USD 26.4 Billion |
Growth Rate from 2023 to 2032 |
CAGR of 5.2% |
Base year |
2022 |
Forecast period |
2023 to 2032 |
Segments covered |
Stage, Indication, Sales channel |
Regional scope |
North America; Europe; Asia Pacific; Central and South America; the Middle East and Africa |
Key companies profiled |
Abbott Laboratories; Pfizer Inc.; Bayer AG; Nestle S.A.; GlaxoSmithKline plc; Baxter International Inc.; Otsuka Holdings Co.; Ltd.; Mead Johnson & Company; LLC; Danone Nutricia; Victus; Inc. |
The Oral clinical nutrition are the supplements such electrolytes, protein, fibre, energy, vitamins and minerals essential for the people with nutrient deficiency. This is due to poor appetite, low food intake and illness. These nutritional products are available in the form of powder, liquid, pudding, fiber, dessert, juices, yogurt and so on which can be consumed orally. They also have a wide range of applications in the treatment of chronic diseases such as cancer, neurological conditions and gastrointestinal disorders.
The key market players are involved in the novel product launch contributing to the global market growth. For instance, in April 2018, Abbott launched a beverage Ensure Protein Max with 2 for people over age 50+ having protein deficiency. The beverage contains 30g protein with 150 calories and 9 amino acids and available in two flavors. The beverage is supplemented with 1g sugar and 22 vitamins and minerals such as Vitamin D, C, and E. Such novel product launch by market players is expected to propel market growth.
Dominant market players are also engaged in collaborations, mergers, acquisitions to enhance the product portfolio and improvise the nutrition portfolio of the company and study the clinical nutrition analysis. This has a positive impact on the global market. For instance, in January 2018, Filament BioSolutions, Inc. entered into a strategic collaboration with CHEO, Ottawa and Ottawa University for a project designed to analyze and study the clinical application of microme-based precision nutrition in IBD. The project was funded by CIHR and Genome Canada.
Moreover, there is rising awareness among people regarding a healthy lifestyle, and consumption of a nutritious diet for improving the body's immunity and living a healthy and fit life. Along with this, there is a rising prevalence of chronic diseases such as cancer. According to the research, loss of appetite, and malnutrition is observed due to the side effects of the clinical treatment. Due to this, the researchers are engaged in formulating oral clinical nutrition supplements by enhancing their nutritional value to counter the side effects of the clinical treatment. This helps in the overall growth of the market. The government and private organizations are investing and raising funds to cater to the problems of malnutrition by improving the R&D and healthcare sector. For instance, in September 2022, Biden-Harris Administration held a White House Conference on Hunger, Nutrition and Health in America to solve the issues of food and proper diet related to nutrient deficiency due to diseases such as diabetes, hypertension, and obesity. The conference stated that over USD 4 billion will be invested by the government in the food nutrition industry to improve the nutritional content in the food and promote a healthy living. Such initiative has led to the development of more advanced and effective oral clinical nutrition supplements, which has increased their adoption and growth in the market.
Further, the COVID-19 pandemic has had a positive impact on the oral clinical nutrition market. The demand for oral clinical nutrition supplements has increased catering to the issues faced due to malnutrition. In order to improve the body's immunity, people have started consuming nutritious food, and supplements enriched with vitamins, fibers, and proteins. Moreover, these supplements are easy to consume. Thus, the global sale of these products has increased in recent years. Market players have also started enhancing the manufacturing capabilities of the food and nutrition departments to cater to the growing demand for quality and regulatory-certified food supplements.
Some of the prominent players in the Oral Clinical Nutrition Market include:
Segments Covered in the Report
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2032. For this study, Nova one advisor, Inc. has segmented the global Oral Clinical Nutrition market.
By Stage
By Indication
By Sales Channel
By Region
Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Research Methodology
1.2.1. Information Procurement
1.3. Information or Data Analysis
1.4. Methodology
1.5. Research Scope and Assumptions
1.6. Market Formulation & Validation
1.6.1. Country Market: Cagr Calculation
1.7. Country Based Segment Share Calculation
1.8. List of Data Sources
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Regional Insights
2.4. Competitive Insights
2.5. Oral Clinical Nutrition Market Snapshot
2.6. Oral Clinical Nutrition Market Segment Snapshot
2.7. Oral Clinical Nutrition Market Competitive Landscape Snapshot
Chapter 3. Oral Clinical Nutrition Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.2.3. Industry Challenge
3.3. Oral Clinical Nutrition Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Bargaining power of the suppliers
3.3.1.2. Bargaining power of the buyers
3.3.1.3. Threats of substitution
3.3.1.4. Threats from new entrants
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Economic and Social landscape
3.3.2.3. Technological landscape
3.4. Impact of COVID-19 on Oral Clinical Nutrition Market
Chapter 4. Oral Clinical Nutrition Market: Stage Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Oral Clinical Nutrition Market: Stage Movement Analysis, 2023 & 2032
4.3. Adults
4.3.1. Adults Market Revenue Estimates and Forecasts, 2020 - 2032
4.4. Pediatrics
4.4.1. Pediatrics Market Revenue Estimates and Forecasts, 2020 - 2032
Chapter 5. Oral Clinical Nutrition Market: Indication Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Oral Clinical Nutrition Market: Stage Movement Analysis, 2023 & 2032
5.3. Alzheimer’s
5.3.1. Alzheimer’s Market Revenue Estimates and Forecasts, 2020 - 2032
5.4. Nutrition Deficiency
5.4.1. Nutrition Deficiency Market Revenue Estimates and Forecasts, 2020 - 2032
5.5. Cancer Care
5.5.1. Cancer Care Market Revenue Estimates and Forecasts, 2020 - 2032
5.6. Diabetes
5.6.1. Diabetes Market Revenue Estimates and Forecasts, 2020 - 2032
5.7. Chronic Kidney Diseases
5.7.1. Chronic Kidney Diseases Market Revenue Estimates and Forecasts, 2020 - 2032
5.8. Orphan Diseases
5.8.1. Orphan Diseases Market Revenue Estimates and Forecasts, 2020 - 2032
5.9. Dysphagia
5.9.1. Dysphagia Market Revenue Estimates and Forecasts, 2020 - 2032
5.10. Pain Management
5.10.1. Pain Management Market Revenue Estimates and Forecasts, 2020 - 2032
5.11. Malabsorption/GI Disorder/Diarrhea
5.11.1. Malabsorption/GI Disorder/Diarrhea Market Revenue Estimates and Forecasts, 2020 - 2032
5.12. Others
5.12.1. Others Market Revenue Estimates and Forecasts, 2020 - 2032
Chapter 6. Oral Clinical Nutrition Market: Sales Channel Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Oral Clinical Nutrition Market: Sales Channel Movement Analysis, 2023 & 2032
6.3. Online Sales
6.3.1. Online Sales Market Revenue Estimates and Forecasts, 2020 - 2032
6.4. Retail Sales
6.4.1. Retail Sales Market Revenue Estimates and Forecasts, 2020 - 2032
6.5. Institutional Sales
6.5.1. Institutional Sales Market Revenue Estimates and Forecasts, 2020 - 2032
Chapter 7. Oral Clinical Nutrition Market: Regional Estimates & Trend Analysis
7.1. Oral Clinical Nutrition Market Share, By Region, 2023 & 2032, USD Million
7.2. North America
7.2.1. North America Oral Clinical Nutrition Market estimates and forecasts, 2020 - 2032
7.2.2. U.S.
7.2.2.1. U.S. Oral Clinical Nutrition Market estimates and forecasts, 2020 - 2032
7.2.3. Canada
7.2.3.1. Canada Oral Clinical Nutrition Market estimates and forecasts, 2020 - 2032
7.3. Europe
7.3.1. Europe Oral Clinical Nutrition Market estimates and forecasts, 2020 - 2032
7.3.2. U.K.
7.3.2.1. U.K. Oral Clinical Nutrition Market estimates and forecasts, 2020 - 2032
7.3.3. Germany
7.3.3.1. Germany Oral Clinical Nutrition Market estimates and forecasts, 2020 - 2032
7.3.4. France
7.3.4.1. France Oral Clinical Nutrition Market estimates and forecasts, 2020 - 2032
7.3.5. Italy
7.3.5.1. Italy Oral Clinical Nutrition Market estimates and forecasts, 2020 - 2032
7.3.6. Spain
7.3.6.1. Spain Oral Clinical Nutrition Market estimates and forecasts, 2020 - 2032
7.3.7. Denmark
7.3.7.1. Denmark Oral Clinical Nutrition Market estimates and forecasts, 2020 - 2032
7.3.8. Norway
7.3.8.1. Norway Oral Clinical Nutrition Market estimates and forecasts, 2020 - 2032
7.3.9. Sweden
7.3.9.1. Sweden Oral Clinical Nutrition Market estimates and forecasts, 2020 - 2032
7.4. Asia Pacific
7.4.1. Asia Pacific Oral Clinical Nutrition Market estimates and forecasts, 2020 - 2032
7.4.2. China
7.4.2.1. China Oral Clinical Nutrition Market estimates and forecasts, 2020 - 2032
7.4.3. Japan
7.4.3.1. Japan Oral Clinical Nutrition Market estimates and forecasts, 2020 - 2032
7.4.4. India
7.4.4.1. India Oral Clinical Nutrition Market estimates and forecasts, 2020 - 2032
7.4.5. Thailand
7.4.5.1. Thailand Oral Clinical Nutrition Market estimates and forecasts, 2020 - 2032
7.4.6. South Korea
7.4.6.1. South Korea Oral Clinical Nutrition Market estimates and forecasts, 2020 - 2032
7.4.7. Australia
7.4.7.1. Australia Oral Clinical Nutrition Market estimates and forecasts, 2020 - 2032
7.5. Latin America
7.5.1. Latin America Oral Clinical Nutrition Market estimates and forecasts, 2020 - 2032
7.5.2. Brazil
7.5.2.1. Brazil Oral Clinical Nutrition Market estimates and forecasts, 2020 - 2032
7.5.3. Mexico
7.5.3.1. Mexico Oral Clinical Nutrition Market estimates and forecasts, 2020 - 2032
7.5.4. Argentina
7.5.4.1. Argentina Oral Clinical Nutrition Market estimates and forecasts, 2020 - 2032
7.6. Middle East and Africa
7.6.1. Middle East and Africa Oral Clinical Nutrition Market estimates and forecasts, 2020 - 2032
7.6.2. South Africa
7.6.2.1. South Africa Oral Clinical Nutrition Market estimates and forecasts, 2020 - 2032
7.6.3. Saudi Arabia
7.6.3.1. Saudi Arabia Oral Clinical Nutrition Market estimates and forecasts, 2020 - 2032
7.6.4. UAE
7.6.4.1. UAE Oral Clinical Nutrition Market estimates and forecasts, 2020 - 2032
7.6.5. Kuwait
7.6.5.1. Kuwait Oral Clinical Nutrition Market estimates and forecasts, 2020 - 2032
Chapter 8. Competitive Landscape
8.1. Company Overview
8.2. Financial Analysis
8.3. Product Benchmarking
8.4. Strategy Mapping
8.4.1. Product Launch
8.4.2. Acquisition
8.4.3. Collaboration
8.5. Recent Developments & Impact Analysis, by Key Market Participants
8.6. Company/Competition Categorization
8.7. List of key emerging companies/technology disruptors/innovators
8.8. Company Market Position AnalysisPfizer Inc.
8.8.1 Bayer AG
8.8.2 Nestle S.A.
8.8.3 GlaxoSmithKline plc
8.8.4 Baxter International Inc.
8.8.5 Otsuka Holdings Co., Ltd.
8.8.6 Mead Johnson & Company, LLC
8.8.7 Danone Nutricia, Victus, Inc.